Clinical Infectious Diseases · 2024 · 15 citations · 12 references
Veterinary MedicineInfectious DiseasesClinical EpidemiologyEpidemiologyInfectious Disease EpidemiologyBacterial EpidemiologyBacterial InfectionsCarbapenem ResistanceDisease Risk AssessmentIncidence StudiesInfectious Disease ScreeningBeta-lactamase GenesCarbapenem-resistant EnterobacteralesCohort Study InvestigationEnterobacterales InfectionsEpidemiology Of Bacterial InfectionsKlebsiella Pneumoniae CarbapenemaseOxacillinase CarbapenemasesRisk Factors For Bloodstream Infection
BACKGROUND: Little is known about the risk of progression from carbapenemase-producing Enterobacterales (CPE) carriage to CPE bloodstream infection (BSI) outside of high-risk settings. We aimed to determine the incidence of CPE BSI among CPE carriers and to assess whether the incidence differs by carbapenemase, species, and setting. METHODS: We conducted a nationwide population-based retrospective cohort study using national databases. The cohort consisted of all patients in Israel with CPE detected by screening from 1 January 2020 to 10 October 2022. We calculated the cumulative incidence of CPE BSI within 1 year among CPE carriers. We used a competing-risks model with BSI as the outcome and death as the competing risk. RESULTS: The study included 6828 CPE carriers. The cumulative incidence of CPE BSI was 2.4% (95% confidence interval [CI], 2.1-2.8). Compared with Klebsiella pneumoniae carbapenemase (KPC), the subhazard of BSI was lower for New Delhi metallo-β-lactamase (NDM) (adjusted subhazard ratio [aSHR], 0.72; 95% CI, .49-1.05) and oxacillinase-48-like (OXA-48-like) (aSHR, 0.60; 95% CI, .32-1.12) but these differences did not reach statistical significance. Compared with K. pneumoniae, the subhazard of BSI was lower for carriers of carbapenemase-producing Escherichia coli (aSHR, 0.33; 95% CI, .21-.52). The subhazard of BSI was higher among patients with CPE carriage first detected in intensive care units (aSHR, 2.10; 95% CI, 1.27-3.49) or oncology/hematology wards (aSHR, 3.95; 95% CI, 2.51-6.22) compared with medical wards. CONCLUSIONS: The risk of CPE BSI among CPE carriers is lower than previously reported in studies that focused on high-risk patients and settings. The risk of BSI differs significantly by bacterial species and setting, but not by carbapenemase.
12
Mitchell J. Schwaber, Baruch Lev, A Israeli et al. · Clinical Infectious Diseases · 2011 · 455 citations
Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17
Maddalena Giannella, Enrico Maria Trecarichi, Francesco Giuseppe De Rosa et al. · Clinical Microbiology and Infection · 2014 · 257 citations · Full text
Life Sciences, Infectious Diseases, Antimicrobial Resistance +16
Xiaohua Qin, Shi Wu, Min Hao et al. · The Journal of Infectious Diseases · 2019 · 186 citations
David M. Livermore, David P. Nicolau, Katie L. Hopkins et al. · Clinical Infectious Diseases · 2020 · 78 citations · Full text